The U.S. Food and Drug Administration expanded the use of Rhythm Pharmaceuticals’  therapy for a rare form of obesity ​caused ...

Lilly is betting big on retatrutide as the next pillar of its obesity portfolio after its weight loss injection Zepbound and ...

Obesity is a chronic disease that can significantly affect an individual’s overall health. In this Care Cues, experts discuss ...

Muscle mass increased or remained stable relative to body weight in middle-aged mice and humans on GLP-1 drugs.

Current childhood obesity prevention programs mostly focus on nutrition education and physical activity, which too often fail ...

Imcivree’s approval in a type of obesity driven by brain injury could unlock an opportunity Wall Street analysts believe to ...

A deluge of weight-loss drugs is set to transform the global fight against obesity as India prepares to unleash low-cost ...

North Dakota has the fifth-lowest childhood obesity rates in the country, but the state's obesity rates increase into ...

At its peak, Imcivree’s sales in hypothalamic obesity could reach over $2 billion worldwide, according to analysts at Stifel.

A new Pediatrics study is putting a spotlight on something most parents don’t think about when it comes to kids’ health: ...

ALMOST all of the food products marketed to Filipino children do not meet global standards, the United Nations Children’s ...

Nearly 1 in 5 teens in the United States is obese, putting their long-term health at serious risk. Obesity in adolescence ...